Panoramic Science closes Pre A round, raises more than RMB100m

Panoramic Science announced the completion of the Pre A round of financing, raising more than 100 million yuan. Proceeds from the fresh round of financing will provide support for production, market expansion and research and development of next-generation products.

Panoramic Science announced the completion of the Pre A round of financing, raising more than 100 million yuan. Proceeds from the fresh round of financing will provide support for production, market expansion and research and development of next-generation products.

A subsidiary of the Hengsheng Medical, Panoramic Science is a medical device company focused on the research and development of cardiovascular and intraluminal imaging technologies. The founder, Zhao Xusheng, served as the chief representative of the American Optical Laboratory China and introduced the first OCT to China.

Hengyi Medical, another subsidiary of Hengsheng Medical, owns “self-perfusion drug-eluting balloons”, “self-perfusion ultra-thin fully degradable stents”, “drug eluting stents”, “balloon catheters”, accessories and other products. In China, it is second only to MicroPort and Lepu Medical.

Among them, the world’s original “self-perfusion drug-eluting balloon” with the famous Chinese cardiovascular expert Professor Huo Yong as the main researcher is about to end clinical enrollment, and the self-perfusion ultra-thin fully degradable stent is expected to enter clinical trials in the fourth quarter of 2021.

Plus the intra-cavity imaging technology to be expanded by this financing, Hengsheng Medical will show its strength in the market for the international comprehensive development of the “diagnosis + treatment” value chain in the future.

Disclaimer: This is an article created by Michael Liang for Chinasdg.org. You can find the original article here: https://chinasdg.org/2020/05/10/panoramic-science-closes-pre-a-round-raises-more-than-rmb100m/.

Leave a Reply

Please Login to Comment